Financial Engines Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.46M | Buy |
6,056
+298
| +5% | +$121K | ﹤0.01% | 199 |
|
2025
Q1 | $2.87M | Buy |
5,758
+16
| +0.3% | +$7.96K | 0.01% | 167 |
|
2024
Q4 | $2.99M | Buy |
5,742
+5,197
| +954% | +$2.7M | 0.01% | 176 |
|
2024
Q3 | $337K | Buy |
+545
| New | +$337K | ﹤0.01% | 320 |
|
2024
Q2 | – | Sell |
-597
| Closed | -$347K | – | 366 |
|
2024
Q1 | $347K | Buy |
597
+101
| +20% | +$58.7K | ﹤0.01% | 273 |
|
2023
Q4 | $263K | Buy |
+496
| New | +$263K | ﹤0.01% | 280 |
|
2023
Q2 | – | Sell |
-448
| Closed | -$258K | – | 303 |
|
2023
Q1 | $258K | Sell |
448
-469
| -51% | -$270K | ﹤0.01% | 258 |
|
2022
Q4 | $505K | Buy |
917
+89
| +11% | +$49K | ﹤0.01% | 211 |
|
2022
Q3 | $420K | Sell |
828
-9
| -1% | -$4.57K | ﹤0.01% | 212 |
|
2022
Q2 | $454K | Buy |
837
+11
| +1% | +$5.97K | ﹤0.01% | 212 |
|
2022
Q1 | $488K | Buy |
826
+282
| +52% | +$167K | ﹤0.01% | 202 |
|
2021
Q4 | $363K | Sell |
544
-1,243
| -70% | -$829K | ﹤0.01% | 188 |
|
2021
Q3 | $1.02M | Buy |
1,787
+154
| +9% | +$88K | ﹤0.01% | 114 |
|
2021
Q2 | $824K | Buy |
1,633
+323
| +25% | +$163K | ﹤0.01% | 112 |
|
2021
Q1 | $598K | Buy |
1,310
+53
| +4% | +$24.2K | ﹤0.01% | 149 |
|
2020
Q4 | $586K | Sell |
1,257
-9
| -0.7% | -$4.2K | ﹤0.01% | 152 |
|
2020
Q3 | $559K | Buy |
+1,266
| New | +$559K | ﹤0.01% | 151 |
|
2018
Q1 | – | Sell |
-8
| Closed | -$2K | – | 225 |
|
2017
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 157 |
|
2017
Q2 | – | Sell |
-30
| Closed | -$5K | – | 117 |
|
2017
Q1 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 67 |
|